The S protein of bovine coronavirus (BCV) has been isolated from the viral membrane and purified by gradient centrifugation. Purified S protein was identified as a viral hemagglutinin. Inactivation of the cellular receptors by sialate 9-O-acetylesterase and generation of receptors by sialylation of erythrocytes with N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2) indicate that S protein recognizes 9-O-acetylated sialic acid as a receptor determinant as has been shown previously for intact virions. The second glycoprotein of BCV, HE, which has been thought previously to be responsible for the hemagglutinating activity of BCV, is a less efficient hemagglutinin; it agglutinates mouse and rat erythrocytes, but in contrast to S protein, it is unable to agglutinate chicken erythrocytes, which contain a lower level of Neu5,9Ac2 on their surface. S protein is proposed to be responsible for the primary attachment of virus to cell surface receptors. The potential of S protein as a probe for the detection of Neu5,9Ac2-containing glycoconjugates is demonstrated.
Many viruses are able to agglutinate erythrocytes. The interactions of the viral hemagglutinins with the surface of erythrocytes have served as a useful model system for analysis of the surface receptors for several viruses, e.g., influenza viruses, paramyxoviruses, and encephalomyocarditis virus (16) . Some strains of coronaviruses are also known to have hemagglutinating activity. Strains which contain only two glycoproteins, M and S, are devoid of hemagglutinating activity or have only a low level of activity. In the case of infectious bronchitis virus, this low hemagglutinating activity is a function of the S protein (1) . The nature of the receptor on the surface of the erythrocytes is not known. Several strains of coronaviruses are quite potent hemagglutinating agents: bovine coronavirus (BCV), hemagglutinating encephalomyelitis virus (HEV), human coronavirus OC-43, turkey coronavirus, and some murine coronaviruses. Characteristic for this group of viruses is the presence of an additional glycoprotein, HE, which has a structural and functional relationship to the glycoprotein HEF of influenza C virus. Both of these glycoproteins can act as receptor-destroying enzymes by virtue of a sialate 9-O-acetylesterase activity (6, 10, 21, 24, 25, 26) . The influenza C glycoprotein is also a hemagglutinin (5, 6, 24) which recognizes N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2) as a receptor determinant for attachment to cells (19) . Hemagglutination by BCV, HEV, and OC-43 is also dependent on Neu5,9Ac2-containing receptors (20, 26) , though they differ from influenza C virus in binding efficiency (20) . The hemagglutinating activity of BCV has been assigned to the HE protein. The evidence is based on the finding that treatment of BCV with bromelain results in the proteolysis of S protein, whereas HE as well as the hemagglutinating activity of the virus particles remain unaffected (12) . In addition, some monoclonal antibodies directed against HE prevent BCV from agglutinating erythrocytes (17) .
Here we report the isolation of the S protein of BCV. The purified glycoprotein was (6) .
Growth and purification of virus. BCV was grown in MDCK I cells as reported recently (20) . Virus was harvested from the supernatant of infected MDCK I cells 48 h postinfection. After clarification of the medium by low-speed centrifugation (2,000 x g, 10 min), virus was sedimented by ultracentrifugation at 112,000 x g for 1 h. The pellet was resuspended in phosphate-buffered saline (PBS) and layered on a sucrose gradient (5 to 50% [wt/wt] in PBS). After centrifugation at 148,000 x g for 40 min, the virus band was collected, diluted with PBS, and sedimented under the same centrifugation conditions. The virus pellet was resuspended in PBS and used for purification of the viral glycoproteins.
Isolation and purification of viral glycoproteins. Viral glycoproteins were isolated by treatment with n-octylglucopyranoside and purified by sucrose-gradient centrifugation as described recently (21) .
Hemagglutination assay. Hemagglutination assays were performed as described previously (9) , using either chicken or rat erythrocytes. The hemagglutination titer (HA titer) indicates the reciprocal value of the maximum dilution that caused complete agglutination.
SDS-polyacrylamide gel electrophoresis. Analysis of proteins by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis was performed as described previously (6) .
Assay for acetylesterase activity. The esterase activity of (20) . Cells were sialylated essentially as described by Paulson and Rogers (18) , using rat liver GalB1,4GlcNAc a-2,6-sialyltransferase. A 10% suspension of human erythrocytes was prepared in a buffer containing 0.1 M NaCl, 20 mM CaCl2, and 50 mM morpholinoethanesulfonic acid (MES), pH 6.5. Samples containing 0.1 ml of the erythrocyte suspension were incubated with 50 mU of neuraminidase from Vibrio cholerae. After 30 min at 37°C, the cells were washed twice with PBS and resuspended with 50 ,u of PBS-1% bovine serum albumin. Following addition of 2 mU of Gal,1,4GlcNAc a-2,6-sialyltransferase and the amount of CMP-sialic acid indicated, the erythrocytes were incubated at 37°C for 3 h. The cells were washed twice, resuspended in 5 ml of PBS, and used to determine the HA titer of BCV and S protein.
Binding assay for the detection of Neu5,9Ac2-containing glycoproteins. Rat serum proteins were separated by SDSpolyacrylamide gel electrophoresis under nonreducing conditions and blotted on a nitrocellulose sheet. The electroblotting method described by Kyhse-Andersen (13) was modified by lowering the pH values of the two buffers at the anode site to 9.0 and 7.4, respectively. Nonspecific binding sites were blocked with 10% nonfat dry milk in PBS overnight at 4°C. The nitrocellulose strips were washed three times for 5 min with PBS-0.1% Tween and incubated for 1 h at 37°C with PBS, acetylesterase of BCV (200 mU), or 0.1 N NaOH. All subsequent steps were performed at 4°C. Following three washes with PBS-Tween, the nitrocellulose was incubated for 1 h with BCV, S protein, or diisopropylfluorophosphate (DFP)-treated HE protein. After being washed with PBS-Tween, strips were incubated with rabbit antiserum directed against BCV (1:1,000 dilution). The nitrocellulose was again washed three times and then incubated for 1 h with biotinylated anti-rabbit donkey immunoglobulins. The strips were washed, incubated with streptavidin-biotinylated horseradish peroxidase complex (1 h), and washed again. Bound BCV, HE protein, or S protein was detected by incubation of the nitrocellulose with PBS, 4-chloro-1-naphthol, and H202 (500:100:1).
Bromelain treatment. BCV was treated with bromelain as described by Compans et al. (3) Fig. 2, the peak of the esterase activity was found in fraction 6, which contained HE (Fig. 1) (15) . Many rosettes were also detected when the gradient fraction containing S protein was analyzed by electron microscopy (Fig. 3) .
S protein recognizes Neu5,9Ac2 as a receptor determinant. The result from Fig. 2 raised the question of whether the hemagglutination caused by purified S protein was related to the agglutinating activity of intact virions. Therefore, BCV and purified S protein were analyzed for their ability to agglutinate erythrocytes from different sources. As shown in (Fig. 4) . The protease has no effect on HE, as shown not only by the protein pattern but also by comparison of the esterase activities of treated and untreated virus (Table 3) . For hemagglutination' titration, King and coworkers had used mo'use erythrocytes, which are known to contain a high level of Neu5,9Ac2, accounting for more. than 50% of the total sialic acid on the cell surface (22) . For convenience, we used rat erythrocytes, which contain similar levels of 9-0-acetylated sialic acid (22) . As shown in Table 3 We reexamined the hemagglutinating activity of gradientpurified HE protein by using rat erythrocytes rather than chicken cells. As shown in Table 4 , HE was indeed able to agglutinate rat erythrocytes. The HA titer determined for the undiluted HE fraction was comparable to the titer obtained by a 1:100 dilution of the S-containing fraction. As S and HE proteins are present in comparable amounts in the original gradient fractions (Fig. 1, lanes b, c, e , and f), the result from Table'4 confirms that S protein is more efficient than HE protein in agglutinating rat erythrocytes. We also analyzed whether S and HE proteins recognize the same type of receptors on rat erythrocytes. After pretreatment of the cells with purified acetylesterase, the HA titer was reduced 'by more than 90% for BCV as well as for S and HE proteins. The hemagglutinating activity of S protein appeared to be somewhat more sensitive to esterase treatment than that of HE protein. This result indicates that both S and HE proteins use 9-O-acetylated sialic acid as the major receptor determinant for agglutination of erythrocytes. Subtle differences in the receptor specificity cannot be excluded at the present time.
S protein is a probe for detection of Neu5,9Ac2. Because of its reactivity, S protein might be a useful analytical tool for detection of Neu5,9Ac2 on glycoconjugates or on cell surfaces. To test this possibility, a solid-phase binding assay has been developed in which test proteins are blotted to nitrocellulose. Rat serum proteins are used because they are known to contain potent hemagglutination inhibitors for influenza C virus as well as for BCV and HEV (20, 23) . This characteristic indicates that they are a rich source of 9-0-acetylated sialic acid, which has been proven by chemical analysis in the case of rat al-macroglobulin (7) . Following SDS-polyacrylamide gel electrophoresis of rat serum, the proteins were blotted to nitrocellulose. BCV and purified S protein were analyzed for their ability to recognize any of the serum components. As shown in Fig. 5 With respect to the distribution of activities among the glycoproteins, there is some similarity between BCV and influenza A viruses. The influenza virus hemagglutinin has receptor-binding and fusion activity just like the S protein of coronaviruses. The second glycoprotein, the neuraminidase, has receptor-destroying activity and is therefore comparable to HE. There are different subtypes of influenza neuraminidases, and most of them lack hemagglutinating activity. The purified neuraminidase of the N9 subtype, however, is a very potent hemagglutinin (14) . The binding activity of this neuraminidase appears not to be essential for the attachment of influenza virus to the cell surface. In the case of coronaviruses, we cannot exclude the possibility that the HE protein has a supporting function in the attachment of virions to cell surfaces. The fact that coronaviruses with a strong hemagglutinating activity such as BCV, HEV, and human coronavirus OC-43 have an HE protein might be interpreted in this way. However, it is also possible that the differences in the hemagglutination efficiency reflect differences in the binding activity of S protein. In this case, viruses with a strong hemagglutinating activity may require the HE protein as a receptor-destroying enzyme. Using Neu5,9Ac2 as a receptor determinant, these viruses will attach not only to surface receptors but also to glycoconjugates which will not allow the initiation of an infection. The receptor-destroying enzyme can inactivate such false receptors and therefore raises the chances of coronaviruses infecting their target cells.
The importance of 9-O-acetylated sialic acids is not restricted to their function as receptor determinants for virus attachment. They play a role also as developmental markers on cells (8) and may be involved in tumor antigens (2) . Recently, influenza C virus has been used as a specific probe to detect Neu5,9Ac2. In the future, it may be preferable to use the S protein of BCV for such purposes. In contrast to the HEF protein of influenza C virus and the HE protein of coronaviruses, S protein retains its activity after isolation from the viral membrane and can therefore be used as a purified protein. Another advantage of S protein is its lack of an acetylesterase activity which counteracts the binding activity. Consequently, one can avoid the handling of toxic inhibitors such as DFP, to inactivate the esterase. Therefore, the S protein of BCV and related coronaviruses should be a useful tool for the analysis of 9-0-acetylated sialic acids.
